We are live on
!
Find out more
KIC
Kensington Investment Counsel Portfolio holdings
AUM
$208M
1-Year Est. Return
11.99%
This Fund
S&P 500
This Quarter
Est. Return
-12.42%
1 Year Est. Return
+11.99%
3 Year Est. Return
+61.57%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$117M
AUM Growth
-$33.9M
(-22%)
Cap. Flow
-$15.3M
Cap. Flow
% of AUM
-13.02%
Top 10 Holdings %
Top 10 Hldgs %
27.86%
Holding
89
New
2
Increased
6
Reduced
66
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$998K |
| 2 |
Repligen
RGEN
|
+$696K |
| 3 |
Salesforce
CRM
|
+$639K |
| 4 |
Verizon
VZ
|
+$130K |
| 5 |
Illinois Tool Works
ITW
|
+$100K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regions Financial
RF
|
+$3.25M |
| 2 |
KeyCorp
KEY
|
+$3.15M |
| 3 |
Citizens Financial Group
CFG
|
+$2.96M |
| 4 |
Intel
INTC
|
+$2.14M |
| 5 |
Cathay General Bancorp
CATY
|
+$1.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.99% |
| 2 | Healthcare | 21.69% |
| 3 | Industrials | 12.21% |
| 4 | Financials | 11.25% |
| 5 | Consumer Staples | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNCE
76
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $321K | 0.27% |
76,354
-395
| -0.5% | -$1.56K |
|
77
Meta Platforms (Facebook)
META
$1.47T
| $314K | 0.27% |
1,948
+56
| +3% | +$10.8K |
|
78
Costco
COST
$421B
| $289K | 0.25% |
603
| – | – |
|
79
Chubb
CB
$132B
| $234K | 0.2% |
1,190
| – | – |
|
|
UMH
80
UMH Properties
UMH
$1.39B
| $194K | 0.17% |
11,000
| – | – |
|
|
81
Cathay General Bancorp
CATY
$4.3B
| – | – |
-30,632
| Closed | -$1.37M |
|
|
82
Citizens Financial Group
CFG
$31.1B
| – | – |
-65,412
| Closed | -$2.96M |
|
83
iShares S&P Mid-Cap 400 Value ETF
IJJ
$9.03B
| – | – |
-9,843
| Closed | -$1.08M |
|
|
84
Intel
INTC
$509B
| – | – |
-43,250
| Closed | -$2.14M |
|
85
iShares Russell 2000 Value ETF
IWN
$14.6B
| – | – |
-3,574
| Closed | -$577K |
|
|
86
KeyCorp
KEY
$24.5B
| – | – |
-140,754
| Closed | -$3.15M |
|
|
87
Regions Financial
RF
$26.9B
| – | – |
-146,155
| Closed | -$3.25M |
|
88
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| – | – |
-1,028
| Closed | -$464K |
|
|
CERN
89
DELISTED
Cerner Corp
CERN
| – | – |
-5,771
| Closed | -$540K |
|
Similar funds
HCA
FHWM
SNBOSD
MIP
SG
MPCG
EPG
CC
Kensington Investment Counsel's Q2 2022 Portfolio in Review
As of Q2 2022, Kensington Investment Counsel held 89 positions worth $117M, down 22% from $151M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Kensington Investment Counsel withdrew a net $15.3M in Q2 2022, closing 9 positions and reducing 66 holdings. Its most notable exit was Regions Financial, an estimated $3.25M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Kensington Investment Counsel opened a new position in Thermo Fisher Scientific worth $985K.
- Kensington Investment Counsel's largest Q2 2022 buy was Thermo Fisher Scientific: 1,813 shares worth $985K.
- Kensington Investment Counsel added most to Repligen in Q2 2022, an estimated $696K increase.
- Kensington Investment Counsel's biggest Q2 2022 reduction was Qualcomm, cutting an estimated $118K.
- Kensington Investment Counsel fully exited Regions Financial in Q2 2022, selling an estimated $3.25M.
- Kensington Investment Counsel's ten largest holdings make up 28% of its $117M portfolio in Q2 2022.
- Kensington Investment Counsel opened 2 new positions and closed 9 in Q2 2022.
- Kensington Investment Counsel's portfolio value fell 22% quarter-over-quarter to $117M.
Based on Kensington Investment Counsel's 13F filing for Q2 2022, filed 15 Jul 2022.